At DCAT’s Biologics Forum & Networking Reception on Mar. 16 in NYC you’ll hear from the FDA, Amgen, Genentech and others about requirements, trends and best practices for subcutaneous biologic drug delivery systems. Learn how suppliers are integrating with their regulatory and pharmaceutical stakeholders to drive innovation in products, tools and practices. A networking reception following the program will provide opportunities for interaction with industry leaders. Special offer: Non-member company representatives are invited to attend at the DCAT member price ($99). Download the details.